the fluid also contains several apoptotic mediators, such as TRAIL, perforin, granzyme, TNF-, soluble FasL, and granulysin [27, 31,32,33,34,35,36]
References: Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA
Daily research amount 300 mcg 5 mg + 1 mL BAC water 6 units 5 mg + 2 mL BAC water 12 units 5 mg + 3 mL BAC water 18 units Daily research amount 500 mcg 5 mg + 1 mL BAC water 10 units 5 mg + 2 mL BAC water 20 units 5 mg + 3 mL BAC water 30 units U-100 syringes contain 100 units per milliliter
Currently, there are a total of ten FDA-approved indications for hGH therapy [5]: Growth hormone deficiency in children and adults (GHD) Growth failure due to chronic renal insufficiency Muscle wasting due to AIDS Noonan syndrome Prader-Willi syndrome Short bowel syndrome (SBS) Short stature homeobox (SHOX)-containing gene deficiency Small-for-gestational-age infants Turner syndrome Recombinant hGH therapy can effectively and dose-dependently increase serum GH levels, hence its use in managing the symptoms of GHD in children and adults